Skip to main content

Aldosterone: Clinical Aspects

  • Chapter
  • 189 Accesses

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 163 / 2))

Abstract

Aldosterone is a potent mineralocorticoid synthesized by the outer zone of the adrenal cortex, the zona glomerulosa. Production of aldosterone is stimulated by angiotensin and potassium, but may also be affected by over 20 other endogenous and exogenous substances. Because of its sensitivity to angiotensin, secretion of aldosterone is altered by diseases that affect the kidneys and perturb their release of renin. Examples include renal artery stenos is, which increase s renin secretion, and diabetes, which reduces it. Other disease s that reduce perfusion of the kidneys also alter aldosterone secretion. Examples include heart failure and cirrhos is of the liver, both of which stimulate renin release and increa se ald ostero ne sec ret io n. Disorders of the adrenal cortex can affect aldosterone secretion. Adenomas of th e zona glomerulosa overproduce aldosterone independent of angiotensin. Hypertrophy of the zona glomerulosa causes overproduction of aldosterone because the cells are hypersensitive to angiotensin. The role of aldosterone in common cardiovascular diseases such as heart failure, low-renin essential hypertension, and the hypertension that accompanies obesity, is uncertain. The growing use of plasma aldosterone and renin measurements and the development of new aldosterone antagonists should clarify the importance of this steroid in a variety of disease states

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Bakris GL, Gavras H (1993) Renin in acute and chronic renal failure: implications for treatment. In: Robertson JIS, Nicholls MG(eds) The renin -angiotensin system, vol 2. Gower, London, pp 56.1–56.14

    Google Scholar 

  • Biglieri EG, Herron MA, Brust N (1966) 17-Hydroxylation deficiency in man. J Clin Invest 45:1946–1954

    Article  PubMed  CAS  Google Scholar 

  • Brown JJ, Lever AF, Robertson JI, et al (1979) Are idiopathic hyperaldo steronism and low-renin hypertension variants of essential hypertension? Ann Clin Biochem 16:380–388

    PubMed  CAS  Google Scholar 

  • Brown NJ, Kim K-S, Chen Y-Q, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE (2000) Synergistic effect of adrenal steroid s and angiotensin 11 on plasminogen activator inhibitor-I production. J Clin Endocrinol Metab 85:336–344

    Article  PubMed  CAS  Google Scholar 

  • Brown RD, Wisgerhof M, Carpenter PC, Brown G, Jiang N-S, Kao P, Hegstad R (1979) Adrenal sensitivity to angiotensin 11 and undiscovered aldosterone stimulating factors in hypertension. J Steroid Biochem 11:1043–1050

    Article  PubMed  CAS  Google Scholar 

  • Burmeister P, Scholmerich J, Diener W, Gerok W (1986) Renin, aldosterone and arginine vasopressin in patients with liver cirrhosis: The influence of ascites retransfusion. Eur J Clin Invest 16:117–123

    Article  PubMed  CAS  Google Scholar 

  • Cain JP, Tuck ML, Williams GH et al (1972) The regulation of aldosterone secretion in primary aldosteronism. Am J Med 53:627–637

    Article  PubMed  CAS  Google Scholar 

  • Carey RM (1982) Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin 11 and adrenocorticotropin. J Clin Endocrinol Metab 54:463–469

    Article  PubMed  CAS  Google Scholar 

  • Cody RJ, Covit AB, Schaer GL, Laragh JH, Sealey JE, Feldschuh J (1986) Sodium and water balance in chronic congestive heart failure. J Clin Invest 77:1441–1452

    Article  PubMed  CAS  Google Scholar 

  • Conlin PR, Moore TJ, Williams GH, Hollenberg NK (1993) Rapid modulation of renal and adrenal respon siveness to angiotensin 11. Hyperten sion 22:832–838

    CAS  Google Scholar 

  • Conn JW, Knopf RF, Nesbit RM (1964) Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107:159–172

    Article  PubMed  CAS  Google Scholar 

  • De Chatel R, Weidmann P, Flammer J, Ziegler WH, Beretta-Piccoli C, Vetter W, Reubi FC (1977) Sodium, renin, aldosterone, catecholamin es and blood pressure in diabetes mellitus. Kidney Int 12:412–421

    Article  PubMed  Google Scholar 

  • Edwards CRW, Hayman A (1991) Enzyme protection of the mineralocorticoid receptor: evidence in favour of the hemi-acetal structure of aldosterone. In: Bonvalet JP et al. (eds) Aldosterone: fundamental aspects. John Libbey Eurotext, London, pp 67–76

    Google Scholar 

  • Ehrhart-Bornstein M, Hinson J, Bornstein S, Scherbaum W, Vinson G (1998) Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr Rev 19:101–143

    Article  PubMed  CAS  Google Scholar 

  • Findling JW, Waters VD, Raff H (1987) The dissociation of renin and aldosterone during critical illness. J Clin Endocrinol Metab 64:592–595

    Article  PubMed  CAS  Google Scholar 

  • Goodfriend TL, Ball DL, Elliott ME, Chabhi A, Duong T, Raff H, Schneider EG, Brown RD, Weinberger MH (1993) Fatty acids may regulate aldosterone secretion and mediate some of insulin’s effects on blood pressure. Prostaglandins Leukot Essent Fatty Acids 48:43–50

    Article  PubMed  CAS  Google Scholar 

  • Goodfriend TL, Elliott ME, Atlas SA (1984) Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci 35:1675–1682

    Article  PubMed  CAS  Google Scholar 

  • Goodfriend TL, Egan BM, Kelley DE (1998) Aldosterone in obesity. Endocr Res 24:789–796

    Article  PubMed  CAS  Google Scholar 

  • Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ (1999) Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 7:355362

    Google Scholar 

  • Goodfriend TL, Ball DL, Gardner HW (2002) An oxidized derivative of linoleic acid affects aldosterone secretion by adrenal cells in vitro. Prostaglandins Leukot Essent Fatty Acids 67:163–167

    Article  PubMed  CAS  Google Scholar 

  • Gordon RD, Klemm SA, Tunny TJ (1993) Renin in Bartter’s syndrome. In: Robertson IS, Nicholls MG (eds) The renin-angiotensin system, vol 2. Gower, London, pp 64.1–64.15

    Google Scholar 

  • Greene EL, Kren S, Hostetter TH (1996) Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063–1068

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Goodfriend, T. (2004). Aldosterone: Clinical Aspects. In: Angiotensin Vol. II. Handbook of Experimental Pharmacology, vol 163 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18497-0_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18497-0_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-40641-9

  • Online ISBN: 978-3-642-18497-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics